Who owns Pyxis Oncology, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of PYXS from SEC Form 13F filings across 101 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 101 institutions disclosed 79.8M shares of Pyxis Oncology, Inc. worth $189.8M — about 95.5% of shares outstanding; the largest disclosed holder is GordonMD Global Investments LP. Source: SEC Form 13F filings, parsed by EvidInvest.
101
13F holders
$189.8M
value, 2026 filers
95.5%
of shares outstanding (79.8M sh)
39
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of PYXS's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | GordonMD Global Investments LP | 15.5M | $36.2M | 21.8% | 18.6% | +55.0% |
| 2 | BVF INC/ILNEW | 11.8M | $27.6M | 0.9% | 14.2% | new |
| 3 | ORBIMED ADVISORS LLCNEW | 8.4M | $19.5M | 0.4% | 10% | new |
| 4 | Pfizer Inc | 7.0M | $20.1M | 12.2% | 8.4% | 0.0% |
| 5 | RTW INVESTMENTS, LPNEW | 6.5M | $15.2M | 0.2% | 7.8% | new |
| 6 | Laurion Capital Management LP | 5.0M | $11.6M | 0.2% | 6% | +1.8% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 4.0M | $9.3M | 0.0% | 4.8% | +92.7% |
| 8 | Longaeva Partners L.P. | 2.0M | $4.6M | 0.1% | 2.4% | +460.4% |
| 9 | HEIGHTS CAPITAL MANAGEMENT, INCNEW | 1.3M | $2.9M | 0.6% | 1.5% | new |
| 10 | WELLS FARGO & COMPANY/MN | 1.1M | $2.6M | 0.0% | 1.3% | +392027.4% |
| 11 | BlackRock, Inc. | 1.0M | $2.4M | 0.0% | 1.2% | +19.3% |
| 12 | ARMISTICE CAPITAL, LLCNEW | 1.0M | $2.4M | 0.0% | 1.2% | new |
| 13 | Blue Owl Capital Holdings LPNEW | 1.0M | $2.3M | 0.4% | 1.2% | new |
| 14 | Empery Asset Management, LPNEW | 1.0M | $2.3M | 2.4% | 1.2% | new |
| 15 | Palo Alto Investors LP | 864,277 | $2.0M | 0.3% | 1% | 0.0% |
| 16 | MILLENNIUM MANAGEMENT LLC | 831,700 | $1.9M | 0.0% | 1% | +256.9% |
| 17 | MARSHALL WACE, LLP | 760,093 | $1.8M | 0.0% | 0.9% | -8.5% |
| 18 | 683 Capital Management, LLC | 714,000 | $1.7M | 0.1% | 0.9% | +55.4% |
| 19 | GEODE CAPITAL MANAGEMENT, LLC | 711,162 | $1.7M | 0.0% | 0.9% | +20.2% |
| 20 | Stonepine Capital Management, LLCNEW | 689,000 | $1.6M | 1.0% | 0.8% | new |
| 21 | SPHERA FUNDS MANAGEMENT LTD.NEW | 689,000 | $1.6M | 0.2% | 0.8% | new |
| 22 | Atle Fund Management AB | 663,772 | $1.5M | 0.4% | 0.8% | -31.3% |
| 23 | SUSQUEHANNA INTERNATIONAL GROUP, LLPNEW | 548,145 | $1.3M | 0.0% | 0.7% | new |
| 24 | Hudson Bay Capital Management LPNEW | 503,650 | $1.2M | 0.0% | 0.6% | new |
| 25 | KINGDON CAPITAL MANAGEMENT, L.L.C.NEW | 500,000 | $1.2M | 0.1% | 0.6% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.